Kuniaki Sato

Title(s)Postdoctoral Scholar, Pharmacology
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
ORCID ORCID Icon0000-0001-6014-1911 Additional info
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Biological and genetic characterization of a newly established human external auditory canal carcinoma cell line, SCEACono2. Sci Rep. 2023 11 10; 13(1):19636. Komune N, Sato K, Ono M, Imaizumi A, Masuda S, Itoyama S, Manako T, Kuga R, Hongo T, Kogo R, Onishi H, Nakagawa T. PMID: 37949965; PMCID: PMC10638439.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    2. YAP-Driven Malignant Reprogramming of Epithelial Stem Cells at Single Cell Resolution. Res Sq. 2023 Oct 27. Gutkind JS, Faraji F, Ramirez S, Clubb L, Sato K, Quiroz PA, Galloway W, Mikulski Z, Hoang T, Medetgul-Ernar K, Marangoni P, Jones K, Officer A, Molinolo A, Kim K, Sakaguchi K, Califano J, Smith Q, Klein O, Tamayo P. PMID: 37961717; PMCID: PMC10635308.
      View in: PubMed   Mentions:
    3. Impact of Positive-Margin Resection of External Auditory Canal Squamous Cell Carcinoma. Cancers (Basel). 2023 Aug 27; 15(17). Komune N, Kuga R, Hongo T, Kuga D, Sato K, Nakagawa T. PMID: 37686564; PMCID: PMC10486369.
      View in: PubMed   Mentions:
    4. Subclonal accumulation of immune escape mechanisms in microsatellite instability-high colorectal cancers. Br J Cancer. 2023 10; 129(7):1105-1118. Kobayashi Y, Niida A, Nagayama S, Saeki K, Haeno H, Takahashi KK, Hayashi S, Ozato Y, Saito H, Hasegawa T, Nakamura H, Tobo T, Kitagawa A, Sato K, Shimizu D, Hirata H, Hisamatsu Y, Toshima T, Yonemura Y, Masuda T, Mizuno S, Kawazu M, Kohsaka S, Ueno T, Mano H, Ishihara S, Uemura M, Mori M, Doki Y, Eguchi H, Oshima M, Suzuki Y, Shibata T, Mimori K. PMID: 37596408; PMCID: PMC10539316.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    5. Direct reprogramming of oral epithelial progenitor cells to cancer stem cells at single cell resolution in vivo. bioRxiv. 2023 Jul 26. Faraji F, Ramirez SI, Clubb LM, Sato K, Quiroz PYA, Galloway WMG, Mikulski Z, Hoang TS, Medetgul-Ernar K, Marangoni P, Jones KB, Officer A, Molinolo AA, Kim K, Sakaguchi K, Califano JA, Smith Q, Klein OD, Tamayo P, Gutkind JS. PMID: 37546810; PMCID: PMC10402053.
      View in: PubMed   Mentions:
    6. Convergent genomic diversity and novel BCAA metabolism in intrahepatic cholangiocarcinoma. Br J Cancer. 2023 06; 128(12):2206-2217. Kitagawa A, Osawa T, Noda M, Kobayashi Y, Aki S, Nakano Y, Saito T, Shimizu D, Komatsu H, Sugaya M, Takahashi J, Kosai K, Takao S, Motomura Y, Sato K, Hu Q, Fujii A, Wakiyama H, Tobo T, Uchida H, Sugimachi K, Shibata K, Utsunomiya T, Kobayashi S, Ishii H, Hasegawa T, Masuda T, Matsui Y, Niida A, Soga T, Suzuki Y, Miyano S, Aburatani H, Doki Y, Eguchi H, Mori M, Nakayama KI, Shimamura T, Shibata T, Mimori K. PMID: 37076565; PMCID: PMC10241955.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. GET4 is a novel driver gene in colorectal cancer that regulates the localization of BAG6, a nucleocytoplasmic shuttling protein. Cancer Sci. 2022 Jan; 113(1):156-169. Koike K, Masuda T, Sato K, Fujii A, Wakiyama H, Tobo T, Takahashi J, Motomura Y, Nakano T, Saito H, Matsumoto Y, Otsu H, Takeishi K, Yonemura Y, Mimori K, Nakagawa T. PMID: 34704338; PMCID: PMC8748226.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    8. Pan-cancer methylome analysis for cancer diagnosis and classification of cancer cell of origin. Cancer Gene Ther. 2022 05; 29(5):428-436. Shimizu D, Taniue K, Matsui Y, Haeno H, Araki H, Miura F, Fukunaga M, Shiraishi K, Miyamoto Y, Tsukamoto S, Komine A, Kobayashi Y, Kitagawa A, Yoshikawa Y, Sato K, Saito T, Ito S, Masuda T, Niida A, Suzuki M, Baba H, Ito T, Akimitsu N, Kodera Y, Mimori K. PMID: 34744163.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    9. Genetic and transcriptomic analyses in a rare case of human papillomavirus-related oropharyngeal squamous-cell carcinoma combined with small-cell carcinoma. Cold Spring Harb Mol Case Stud. 2021 10; 7(5). Sato K, Nishiyama K, Taguchi K, Jiromaru R, Yamamoto H, Matsunaga A, Nagata R, Rikimaru F, Toh S, Higaki Y, Oda S, Nakagawa T, Masuda M. PMID: 34462366; PMCID: PMC8559619.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    10. Oxysterol binding protein-like 3 (OSBPL3) is a novel driver gene that promotes tumor growth in part through R-Ras/Akt signaling in gastric cancer. Sci Rep. 2021 09 28; 11(1):19178. Hu Q, Masuda T, Koike K, Sato K, Tobo T, Kuramitsu S, Kitagawa A, Fujii A, Noda M, Tsuruda Y, Otsu H, Kuroda Y, Ito S, Oki E, Mimori K. PMID: 34584127; PMCID: PMC8478956.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    11. Is chemoimmunotherapy a game changer in the treatment of locally advanced head and neck squamous cell carcinoma? Clin Case Rep. 2021 Sep; 9(9):e04793. Masuda M, Nagata R, Hara H, Kuroki K, Sato K, Rikimaru F, Toh S, Higaki Y. PMID: 34584700; PMCID: PMC8457411.
      View in: PubMed   Mentions: 1  
    12. Establishment and characterization of a primary cell culture derived from external auditory canal squamous cell carcinoma. FEBS Open Bio. 2021 Aug; 11(8):2211-2224. Sekino Y, Imaizumi A, Komune N, Ono M, Sato K, Masuda S, Fujimura A, Koike K, Hongo T, Uchi R, Onishi H, Nakagawa T. PMID: 34115931; PMCID: PMC8329851.
      View in: PubMed   Mentions: 2     Fields:    
    13. Programmed Death-Ligand 1 Expression and Tumor-Infiltrating Lymphocytes in Temporal Bone Squamous Cell Carcinoma. Laryngoscope. 2021 12; 131(12):2674-2683. Hongo T, Kuga R, Miyazaki M, Komune N, Nakano T, Yamamoto H, Koike K, Sato K, Kogo R, Nabeshima K, Oda Y, Nakagawa T. PMID: 34143491.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    14. Mitotic checkpoint regulator RAE1 promotes tumor growth in colorectal cancer. Cancer Sci. 2021 Aug; 112(8):3173-3189. Kobayashi Y, Masuda T, Fujii A, Shimizu D, Sato K, Kitagawa A, Tobo T, Ozato Y, Saito H, Kuramitsu S, Noda M, Otsu H, Mizushima T, Doki Y, Eguchi H, Mori M, Mimori K. PMID: 34008277; PMCID: PMC8353924.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    15. Management of Residual Hearing with Cartilage Conduction Hearing Aid after Lateral Temporal Bone Resection: Our Institutional Experience. Audiol Res. 2021 Jun 09; 11(2):263-274. Komune N, Higashino Y, Ishikawa K, Tabuki T, Masuda S, Koike K, Hongo T, Sato K, Uchi R, Miyazaki M, Shimamoto R, Tsuchihashi NA, Kogo R, Noda T, Matsumoto N, Nakagawa T. PMID: 34207894; PMCID: PMC8293261.
      View in: PubMed   Mentions: 5  
    16. Auricular complications following temporal bone resection for temporal bone malignancies: A clinical consideration. Clin Otolaryngol. 2021 09; 46(5):1146-1152. Komune N, Matsuo S, Shimamoto R, Ikemura K, Iwanaga J, Sato K, Yoshida S, Kadota H, Nakagawa T. PMID: 33960128.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. The novel driver gene ASAP2 is a potential druggable target in pancreatic cancer. Cancer Sci. 2021 Apr; 112(4):1655-1668. Fujii A, Masuda T, Iwata M, Tobo T, Wakiyama H, Koike K, Kosai K, Nakano T, Kuramitsu S, Kitagawa A, Sato K, Kouyama Y, Shimizu D, Matsumoto Y, Utsunomiya T, Ohtsuka T, Yamanishi Y, Nakamura M, Mimori K. PMID: 33605496; PMCID: PMC8019229.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    18. Clinical Analysis of En Bloc Resection for Advanced Temporal Bone Squamous Cell Carcinoma. J Neurol Surg B Skull Base. 2022 Jun; 83(Suppl 2):e40-e48. Komune N, Kuga D, Matsuo S, Miyazaki M, Noda T, Sato K, Hongo T, Koike K, Uchi R, Kogo R, Tsuchihashi NA, Masuda S, Nakagawa T. PMID: 35832936; PMCID: PMC9272235.
      View in: PubMed   Mentions: 3  
    19. Prognostic Significance of Systemic Inflammatory Response in Cases of Temporal Bone Squamous Cell Carcinoma. Laryngoscope. 2021 08; 131(8):1782-1789. Komune N, Sato K, Hongo T, Miyazaki M, Masuda S, Koike K, Uchi R, Tsuchihashi NA, Noda T, Kogo R, Wakasaki T, Yasumatsu R, Nakagawa T. PMID: 33538330.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    20. Genomic Sequencing of Cancer-related Genes in Sinonasal Squamous Cell Carcinoma and Coexisting Inverted Papilloma. Anticancer Res. 2021 Jan; 41(1):71-79. Uchi R, Jiromaru R, Yasumatsu R, Yamamoto H, Hongo T, Manako T, Sato K, Hashimoto K, Wakasaki T, Matsuo M, Nakagawa T. PMID: 33419800.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    21. Drug-induced interstitial lung disease in recurrent and/or metastatic head and neck cancer patients treated with cetuximab and/or nivolumab. Oral Oncol. 2021 02; 113:105129. Matsuo M, Yasumatsu R, Masuda M, Toh S, Wakasaki T, Hashimoto K, Uchi R, Jiromaru R, Sato K, Manako T, Nakagawa T. PMID: 33360023.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    22. Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT. PLoS One. 2020; 15(10):e0241140. Hu Q, Masuda T, Kuramitsu S, Tobo T, Sato K, Kidogami S, Nambara S, Ueda M, Tsuruda Y, Kuroda Y, Ito S, Oki E, Mori M, Mimori K. PMID: 33095806; PMCID: PMC7584171.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    23. Prognostic Impact of Tumor Extension in Patients With Advanced Temporal Bone Squamous Cell Carcinoma. Front Oncol. 2020; 10:1229. Komune N, Miyazaki M, Sato K, Sagiyama K, Hiwatashi A, Hongo T, Koike K, Noda T, Uchi R, Kogo R, Akagi Tsuchihashi N, Masuda S, Nakagawa T. PMID: 32850367; PMCID: PMC7427636.
      View in: PubMed   Mentions: 6  
    24. Genetic landscape of external auditory canal squamous cell carcinoma. Cancer Sci. 2020 Aug; 111(8):3010-3019. Sato K, Komune N, Hongo T, Koike K, Niida A, Uchi R, Noda T, Kogo R, Matsumoto N, Yamamoto H, Masuda M, Oda Y, Mimori K, Nakagawa T. PMID: 32500594; PMCID: PMC7419060.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    25. Therapeutic effect of Nivolumab for advanced / recurrent temporal bone squamous cell carcinoma. Auris Nasus Larynx. 2020 Oct; 47(5):864-869. Noda T, Komune N, Yasumatsu R, Tsuchihashi NA, Tamae A, Matsumoto N, Sato K, Uchi R, Koike K, Wakasaki T, Tanaka R, Nakagawa T. PMID: 32446629.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. SF3B4 Plays an Oncogenic Role in Esophageal Squamous Cell Carcinoma. Anticancer Res. 2020 May; 40(5):2941-2946. Kidogami S, Iguchi T, Sato K, Yoshikawa Y, Hu Q, Nambara S, Komatsu H, Ueda M, Kuroda Y, Masuda T, Mori M, Doki Y, Mimori K. PMID: 32366446.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    27. Primary Advanced Squamous Cell Carcinoma of the Temporal Bone: A Single-Center Clinical Study. Laryngoscope. 2021 02; 131(2):E583-E589. Komune N, Noda T, Kogo R, Miyazaki M, Tsuchihashi NA, Hongo T, Koike K, Sato K, Uchi R, Wakasaki T, Matsumoto N, Yasumatsu R, Nakagawa T. PMID: 32267551.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    28. YAP1 is a potent driver of the onset and progression of oral squamous cell carcinoma. Sci Adv. 2020 03; 6(12):eaay3324. Omori H, Nishio M, Masuda M, Miyachi Y, Ueda F, Nakano T, Sato K, Mimori K, Taguchi K, Hikasa H, Nishina H, Tashiro H, Kiyono T, Mak TW, Nakao K, Nakagawa T, Maehama T, Suzuki A. PMID: 32206709; PMCID: PMC7080500.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansAnimals
    29. KIF15 Expression in Tumor-associated Monocytes Is a Prognostic Biomarker in Hepatocellular Carcinoma. Cancer Genomics Proteomics. 2020 Mar-Apr; 17(2):141-149. Kitagawa A, Masuda T, Takahashi J, Tobo T, Noda M, Kuroda Y, Hu Q, Kouyama Y, Kobayashi Y, Kuramitsu S, Sato K, Fujii A, Yoshikawa Y, Wakiyama H, Shimizu D, Tsuruda Y, Eguchi H, Doki Y, Mori M, Mimori K. PMID: 32108036; PMCID: PMC7078836.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    30. N-Cadherin mRNA Levels in Peripheral Blood Could Be a Potential Indicator of New Metastases in Breast Cancer: A Pilot Study. Int J Mol Sci. 2020 Jan 14; 21(2). Masuda T, Ueo H, Kai Y, Noda M, Hu Q, Sato K, Fujii A, Hayashi N, Tsuruda Y, Otsu H, Kuroda Y, Eguchi H, Ohno S, Mimori K, Ueo H. PMID: 31947504; PMCID: PMC7013704.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    31. GTF2IRD1 on chromosome 7 is a novel oncogene regulating the tumor-suppressor gene TGFβR2 in colorectal cancer. Cancer Sci. 2020 Feb; 111(2):343-355. Nambara S, Masuda T, Kobayashi Y, Sato K, Tobo T, Koike K, Noda M, Ogawa Y, Kuroda Y, Ito S, Eguchi H, Sugimachi K, Mimori K. PMID: 31758608; PMCID: PMC7004548.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    32. Stress-triggered YAP1/SOX2 activation transcriptionally reprograms head and neck squamous cell carcinoma for the acquisition of stemness. J Cancer Res Clin Oncol. 2019 Oct; 145(10):2433-2444. Omori H, Sato K, Nakano T, Wakasaki T, Toh S, Taguchi K, Nakagawa T, Masuda M. PMID: 31485767.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    33. Oncogenic splicing abnormalities induced by DEAD-Box Helicase 56 amplification in colorectal cancer. Cancer Sci. 2019 Oct; 110(10):3132-3144. Kouyama Y, Masuda T, Fujii A, Ogawa Y, Sato K, Tobo T, Wakiyama H, Yoshikawa Y, Noda M, Tsuruda Y, Kuroda Y, Eguchi H, Ishida F, Kudo SE, Mimori K. PMID: 31390121; PMCID: PMC6778637.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimalsCells
    34. Novel oncogene 5MP1 reprograms c-Myc translation initiation to drive malignant phenotypes in colorectal cancer. EBioMedicine. 2019 Jun; 44:387-402. Sato K, Masuda T, Hu Q, Tobo T, Gillaspie S, Niida A, Thornton M, Kuroda Y, Eguchi H, Nakagawa T, Asano K, Mimori K. PMID: 31175057; PMCID: PMC6606960.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    35. Multiregion Genomic Analysis of Serially Transplanted Patient-derived Xenograft Tumors. Cancer Genomics Proteomics. 2019 Jan-Feb; 16(1):21-27. Sato K, Niida A, Masuda T, Shimizu D, Tobo T, Kuroda Y, Eguchi H, Nakagawa T, Suzuki Y, Mimori K. PMID: 30587497; PMCID: PMC6348396.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    36. CRMP5-associated GTPase (CRAG) Is a Candidate Driver Gene for Colorectal Cancer Carcinogenesis. Anticancer Res. 2019 Jan; 39(1):99-106. Shimizu D, Masuda T, Sato K, Tsuruda Y, Otsu H, Kuroda Y, Eguchi H, Kodera Y, Mimori K. PMID: 30591445.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    37. Identification of UHRF2 as a Negative Regulator of Epithelial-Mesenchymal Transition and Its Clinical Significance in Esophageal Squamous Cell Carcinoma. Oncology. 2018; 95(3):179-187. Iguchi T, Ueda M, Masuda T, Nambara S, Kidogami S, Komatsu H, Sato K, Tobo T, Ogawa Y, Hu Q, Saito T, Hirata H, Sakimura S, Uchi R, Hayashi N, Ito S, Eguchi H, Sugimachi K, Maehara Y, Mimori K. PMID: 29909415.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    38. Identification of ARL4C as a Peritoneal Dissemination-Associated Gene and Its Clinical Significance in Gastric Cancer. Ann Surg Oncol. 2018 Mar; 25(3):745-753. Hu Q, Masuda T, Sato K, Tobo T, Nambara S, Kidogami S, Hayashi N, Kuroda Y, Ito S, Eguchi H, Saeki H, Oki E, Maehara Y, Mimori K. PMID: 29270876.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    39. Circulating exosomal microRNA-203 is associated with metastasis possibly via inducing tumor-associated macrophages in colorectal cancer. Oncotarget. 2017 Oct 03; 8(45):78598-78613. Takano Y, Masuda T, Iinuma H, Yamaguchi R, Sato K, Tobo T, Hirata H, Kuroda Y, Nambara S, Hayashi N, Iguchi T, Ito S, Eguchi H, Ochiya T, Yanaga K, Miyano S, Mimori K. PMID: 29108252; PMCID: PMC5667985.
      View in: PubMed   Mentions: 87     Fields:    
    40. Phosphoserine Phosphatase Is a Novel Prognostic Biomarker on Chromosome 7 in Colorectal Cancer. Anticancer Res. 2017 05; 37(5):2365-2371. Sato K, Masuda T, Hu Q, Tobo T, Kidogami S, Ogawa Y, Saito T, Nambara S, Komatsu H, Hirata H, Sakimura S, Uchi R, Hayashi N, Iguchi T, Eguchi H, Ito S, Nakagawa T, Mimori K. PMID: 28476802.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    41. Clinical Significance of FANCD2 Gene Expression and its Association with Tumor Progression in Hepatocellular Carcinoma. Anticancer Res. 2017 03; 37(3):1083-1090. Komatsu H, Masuda T, Iguchi T, Nambara S, Sato K, Hu Q, Hirata H, Ito S, Eguchi H, Sugimachi K, Eguchi H, Doki Y, Mori M, Mimori K. PMID: 28314268.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    42. miR-146a Polymorphism (rs2910164) Predicts Colorectal Cancer Patients' Susceptibility to Liver Metastasis. PLoS One. 2016; 11(11):e0165912. Iguchi T, Nambara S, Masuda T, Komatsu H, Ueda M, Kidogami S, Ogawa Y, Hu Q, Sato K, Saito T, Hirata H, Sakimura S, Uchi R, Hayashi N, Ito S, Eguchi H, Sugimachi K, Maehara Y, Mimori K. PMID: 27824903; PMCID: PMC5100922.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    43. Attenuated RND1 Expression Confers Malignant Phenotype and Predicts Poor Prognosis in Hepatocellular Carcinoma. Ann Surg Oncol. 2017 Mar; 24(3):850-859. Komatsu H, Iguchi T, Masuda T, Hirata H, Ueda M, Kidogami S, Ogawa Y, Sato K, Hu Q, Nambara S, Saito T, Sakimura S, Uchi R, Ito S, Eguchi H, Sugimachi K, Eguchi H, Doki Y, Mori M, Mimori K. PMID: 27770342.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    44. HOXB7 Expression is a Novel Biomarker for Long-term Prognosis After Resection of Hepatocellular Carcinoma. Anticancer Res. 2016 Jun; 36(6):2767-73. Komatsu H, Iguchi T, Masuda T, Ueda M, Kidogami S, Ogawa Y, Nambara S, Sato K, Hu Q, Saito T, Hirata H, Sakimura S, Uchi R, Hayashi N, Ito S, Eguchi H, Sugimachi K, Eguchi H, Doki Y, Mori M, Mimori K. PMID: 27272787.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    45. Clinical Significance of Expression of Nephroblastoma Overexpressed (NOV) in Patients with Colorectal Cancer. Anticancer Res. 2015 Dec; 35(12):6591-7. Ueda M, Iguchi T, Komatsu H, Kidogami S, Hu Q, Sato K, Ogawa Y, Nambara S, Saito T, Sakimura S, Hirata H, Uchi R, Shinden Y, Eguchi H, Ito S, Masuda T, Yamamoto H, Doki Y, Mori M, Mimori K. PMID: 26637874.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    Kuniaki's Networks
    Concepts (195)
    Derived automatically from this person's publications.
    Co-Authors (7)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department